Al-Rawhani Amatallah Hussein, Ibrahim Salsabyl Mohamed, Abu Naeem Fatma M
Faculty of Dentistry, Cairo University Address: 11 El-Saraya Str., El-Manyal, Cairo, Egypt.
Faculty of Dentistry, Cairo University, Cairo, Egypt.
Eur Endod J. 2024 Dec 20;9(4):365-373. doi: 10.14744/eej.2024.30075. Epub 2024 Oct 30.
The purpose of this randomized, controlled study was to evaluate the effectiveness of Biodentine compared with MTA used as a pulp space barrier in healing periapical lesions and regaining pulp sensitivity after regenerative treatment in mature single-canal permanent teeth with pulp necrosis and apical periodontitis.
The study involved 36 patients with mature teeth with necrotic pulp and apical periodontitis. The patient underwent a regenerative treatment that utilized the blood clot technique. Teeth were randomly allocated to either the intervention, Biodentine, group (n=18) or the control, MTA, group (n=18). The healing of periapical lesions and tooth sensibility were evaluated throughout follow-up visits for up to 18 months.
The study analyzed 31 patients; two patients within the biodentine group and three in the MTA group were lost to follow-up. After 18 months, both groups showed effective healing of periradicular lesions; 21 out of 31 patients (67.7%) were healed, ten patients (32.3%) were healing, and no failure cases occurred. There were no significant differences between the groups (p=1.00). More than 70% (22 out of 31 patients) regained their sensibility in their teeth, and the groups had no statistically significant difference (p=0.703).
Regenerative treatment using blood clots with either MTA or Biodentine effectively resolved periapical lesions and regained the sensibility of mature teeth.
本随机对照研究旨在评估在成熟的单根管恒牙牙髓坏死和根尖周炎的再生治疗中,与用作牙髓腔屏障的MTA相比,BioDentine在愈合根尖周病变和恢复牙髓敏感性方面的有效性。
该研究纳入了36例患有牙髓坏死和根尖周炎的成熟牙齿患者。患者接受了采用血凝块技术的再生治疗。牙齿被随机分配到干预组(BioDentine组,n = 18)或对照组(MTA组,n = 18)。在长达18个月的随访中评估根尖周病变的愈合情况和牙齿敏感性。
该研究分析了31例患者;BioDentine组有2例患者、MTA组有3例患者失访。18个月后,两组根尖周病变均有效愈合;31例患者中有21例(67.7%)愈合,10例患者(32.3%)正在愈合,未发生失败病例。两组之间无显著差异(p = 1.00)。超过70%(31例患者中的22例)牙齿恢复了敏感性,两组之间无统计学显著差异(p = 0.703)。
使用MTA或BioDentine的血凝块再生治疗有效解决了根尖周病变并恢复了成熟牙齿的敏感性。